Earnings
ATHE
1.280
-7.91%
-0.110
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-06-30
6.36M
--
--
8701.59
--
--
42.42K
--
--
--
392.80K
7089.93
6.80M
49.37K
--
--
--
--
--
--
--
49.37K
6.85M
--
659.90K
0.00
--
--
--
--
--
764.06K
--
--
--
430.93K
1.88M
601.78
--
--
--
28.71K
29.31K
1.91M
111.16M
--
-106.21M
--
--
--
4.95M
4.95M
6.85M
FY 2019-06-30
10.03M
--
--
3.36M
--
--
0.00
--
--
--
--
440.15K
13.84M
33.96K
--
--
--
--
--
--
--
33.96K
13.87M
--
1.89M
0.00
--
--
--
1.89M
--
--
--
--
--
419.41K
2.31M
0.00
--
--
--
24.37K
24.37K
2.34M
109.13M
--
-97.59M
--
--
--
11.53M
11.53M
13.87M
FY 2018-06-30
11.28M
--
--
2.33M
--
--
0.00
--
--
--
--
197.41K
13.81M
52.88K
--
--
--
--
--
--
--
52.88K
13.86M
--
1.52M
0.00
--
--
--
1.52M
--
--
--
--
--
435.87K
1.96M
0.00
--
--
--
681.17
681.17
1.96M
106.55M
--
-94.64M
--
--
--
11.91M
11.91M
13.86M
FY 2017-06-30
28.54M
--
--
3.96M
--
--
0.00
--
--
--
--
429.80K
32.93M
40.19K
--
--
--
--
--
--
0.00
40.19K
32.97M
--
1.16M
0.00
--
--
--
1.16M
--
--
--
--
--
910.24K
2.07M
0.00
--
--
--
573.76
573.76
2.07M
187.80M
--
-156.91M
--
--
--
30.89M
30.89M
32.97M
FY 2016-06-30
38.41M
--
--
6.43M
--
--
0.00
--
--
--
--
371.45K
45.21M
32.55K
--
--
--
--
--
--
59.10K
91.63K
45.31M
--
2.35M
0.00
--
--
--
2.35M
--
--
--
--
--
817.82K
3.17M
0.00
--
--
--
631.40
631.40
3.17M
197.32M
--
-155.18M
--
--
--
42.14M
42.14M
45.31M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ATHE latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Alterity Therapeutics Ltd recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.